13F Data
13F filer · CIK 1465837

Boxer Capital, LLC

San Diego, CA · filing since Q4 2015 · last filing Feb 14, 2025
Reported value
$0
$-2.0B vs prior
Positions
1
New / sold out
1 / 68
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $2.0B
Top-10 weight
–

Biggest buys vs Q3 2024

ChangeSecurityShares changeChange %Est. trade value
New00––

Biggest sells vs Q3 2024

ChangeSecurityShares changeChange %Est. trade value
Sold outRevolution Medicines Inc-4,279,464-100.0%$-194.1M
Sold outTyra Biosciences Inc-6,448,359-100.0%$-151.6M
Sold outNuvalent Inc-1,120,192-100.0%$-114.6M
Sold outBeiGene Ltd-500,000-100.0%$-112.3M
Sold outCytokinetics Inc-2,100,000-100.0%$-110.9M
Sold outSpringworks Therapeutics Inc-3,421,541-100.0%$-109.6M
Sold outMerus N V-1,900,000-100.0%$-94.9M
Sold outSarepta Therapeutics Inc-650,000-100.0%$-81.2M
Sold outAvidity Biosciences Inc-1,727,388-100.0%$-79.3M
Sold outIdeaya Biosciences Inc-2,202,812-100.0%$-69.8M
58 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2015: $115.8MQ1 2016: $102.2MQ2 2016: $112.8MQ3 2016: $223.1MQ4 2016: $258.5MQ1 2017: $457.6MQ2 2017: $420.5MQ3 2017: $439.3MQ4 2017: $547.1MQ1 2018: $936.9MQ2 2018: $883.1MQ3 2018: $901.2MQ4 2018: $809.4MQ1 2019: $864.7MQ2 2019: $1.2BQ3 2019: $1.4BQ4 2019: $1.8BQ1 2020: $1.5BQ2 2020: $2.3BQ3 2020: $2.9BQ4 2020: $3.1BQ1 2021: $2.9BQ2 2021: $2.8BQ3 2021: $2.9BQ4 2021: $2.6BQ1 2022: $1.9BQ2 2022: $1.6BQ3 2022: $1.8BQ4 2022: $1.9BQ1 2023: $2.0BQ2 2023: $2.2BQ3 2023: $1.9BQ4 2023: $2.0BQ1 2024: $2.0BQ2 2024: $1.9BQ3 2024: $2.0BQ4 2024: $0
Q4 2015Q4 2024

Holdings · Q4 2024

#SecuritySharesValueWeight
1000$0–